Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease polycystic ovary syndrome
Comorbidity C0948265|metabolic syndrome
Sentences 47
PubMedID- 21962027 polycystic ovary syndrome (pcos) is associated with the metabolic syndrome (mets).
PubMedID- 24592034 Prediction of metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 22888988 Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 20396356 [clinical features of the metabolic syndrome in patients with polycystic ovary syndrome].
PubMedID- 25787215 pcos women with metabolic syndrome (ms) had lower serum 25(oh)d compared with those without ms (20.6 +/- 8.3 vs 25.9 +/- 11.3 ng/ml, p = 0.049).
PubMedID- 25763280 Given the frequent association of pcos with metabolic syndrome (ms) and changes in glucose metabolism, this study seeks to investigate the presence of early retinal changes in women with pcos as a strategy to prevent ocular involvement.
PubMedID- 21251033 Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
PubMedID- 22578482 Results: the prevalence of overweight and metabolic syndrome in adolescents with pcos was 52% and 33.3% respectively vs 22.4% (p = 0.005) and 11.26% in control (normal) adolescents (p = 0.0001).
PubMedID- 24639812 The articles were summarized and grouped according to different sections defining interactions between pcos with metabolic syndrome and nafld, and found many articles that concluded that nafld is the hepatic manifestation of metabolic syndrome.
PubMedID- 21896560 Fto variants have also been shown to strongly influence the glucose intolerance component of the metabolic syndrome in patients with pcos (attaoua et al., 2008).
PubMedID- 20925278 [the prevalence of metabolic syndrome in women with polycystic ovary syndrome].
PubMedID- 21956415 Context: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome and, consequently, with a potentially increased risk of cardiovascular disease (cvd) and related mortality later in life.
PubMedID- 22985575 [association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome].
PubMedID- 20089210 The focus of this overview is therefore on pcos comorbidity with the metabolic syndrome, type 2 diabetes and cardiovascular diseases.
PubMedID- 21450287 Objective: to determine prevalence of metabolic syndrome in adolescents with polycystic ovary syndrome (pcos) and derive features suggestive of propensity for development of metabolic syndrome.
PubMedID- 21478181 In concert with this finding, most of the associations between markers of adipose tissue inflammation and variables of the metabolic syndrome in patients with pcos were lost when adjusted for age and bmi.
PubMedID- 22870011 Objective: the aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (pcos).
PubMedID- 23426706 Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 21756079 Objective: based on the role of polycystic ovary syndrome as a cause of metabolic syndrome with chronic anovulation, obesity, hyperinsulinemia and hyperandrogenism, development of effective treatment for its obesity is a priority.
PubMedID- 20540665 Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions.
PubMedID- 21114431 Background: both non-alcoholic steatohepatitis (nash) and polycystic ovary syndrome (pcos) are associated with metabolic syndrome (ms) and insulin resistance (ir).
PubMedID- 20852028 Objective: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome.
PubMedID- 23283052 Objective: the aim of this study was to assess the association between premicroalbuminuria and metabolic syndrome in women with polycystic ovary syndrome (pcos).
PubMedID- 21275164 Objective: to evaluate the relation between pi-deficiency syndrome (pds) pattern and metabolic syndrome (ms) in patients with polycystic ovarian syndrome (pcos), for exploring their internal pathologic mechanism.
PubMedID- 24447981 Objective: polycystic ovary syndrome (pcos) is linked with metabolic syndrome, which includes obesity, insulin resistance, dyslipidemia, and endocrine function in patients with pcos.
PubMedID- 23885694 Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 20199774 Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 21282820 Objective: to compare the effects of laparoscopic ovarian drilling in treating infertile polycystic ovarian syndrome in patients with and without metabolic syndrome.
PubMedID- 21277789 Women of reproductive age are not spared from the complications of metabolic syndrome, which overlaps with obesity and polycystic ovary syndrome (pcos), both of which are linked to infertility and poor reproductive outcome.
PubMedID- 20807165 metabolic syndrome in adolescents with polycystic ovary syndrome.
PubMedID- 23619436 Recently, pcos has been associated with the metabolic syndrome.
PubMedID- 20462081 pcos women with metabolic syndrome had significantly higher body mass index, free testosterone index and insulin levels than those without the syndrome.
PubMedID- 26039829 Objective: to determine the prevalence of nafld and metabolic syndrome in patients with pcos, and to verify if there is a correlation between nafld and metabolic syndrome in this population.
PubMedID- 26488852 Targets to treat metabolic syndrome in polycystic ovary syndrome.
PubMedID- 21550088 Both vitamin d deficiency and polycystic ovary syndrome (pcos) are associated with aspects of metabolic syndrome, but it is unclear whether vitamin d deficiency contributes to the metabolic disturbances commonly found in women with pcos.
PubMedID- 20092643 Discussed the potential role of fto variants for the glucose intolerance component of the metabolic syndrome in patients with pcos [13].
PubMedID- 21083920 Results: the prevalence of pre-diabetes, insulin resistance, hyperinsulinemia, dyslipidemia and metabolic syndrome in adolescents with pcos was 11.7%, 46.9%, 29.7%, 22.7% and 4.7%, respectively.
PubMedID- 25884893 Background: pcos is associated with metabolic syndrome, which correlates to increased cardiovascular risk in these patients.
PubMedID- 26052744 Measurements: the factor structure for metabolic syndrome for women with pcos and control groups was examined, specifically, the contribution of individual factors to metabolic syndrome and the association of hyperandrogenism with other metabolic factors.
PubMedID- 22777527 We might have underestimated actual prevalence of metabolic syndrome in pcos due to lack of oral glucose tolerance test 2 h glucose data.
PubMedID- 24719790 Emerging evidence supports a developmental origin for the metabolic syndrome in the context of polycystic ovary syndrome (pcos) in which the fetal environment programs both reproductive and metabolic abnormalities that will occur in adulthood.
PubMedID- 22172592 Obesity is the major link in the association of pcos with diabetes, metabolic syndrome, hypertension, low-grade chronic inflammation and increased body iron stores, among others.
PubMedID- 25693210 The increase rate of metabolic syndrome in adolescents with pcos emphasize the importance of regular screening due to the high cardiometabolic disorders risk.
PubMedID- 23656383 Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome.
PubMedID- 24347934 Clinical and biochemical parameters of pcos women with and without metabolic syndrome was compared [table 2].
PubMedID- 21937505 The prevalence of elevated fli was 88.7% in pcos women with metabolic syndrome (ms) and 11.3% in pcos women without ms (p<0.001).
PubMedID- 25242985 Prevalence of metabolic syndrome in polycystic ovarian syndrome women in a hospital of tehran.

Page: 1